3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
29
Lymphoma, Large B-Cell, Diffuse
26
Burkitt Lymphoma
20
Lymphoma, Follicular
15
Lymphoma
14
Precursor Cell Lymphoblastic Leukemia-Lymphoma
9
Lymphoma, Non-Hodgkin
9
Neoplasms
8
Lymphoma, B-Cell
6
Recurrence
5
Prostatic Neoplasms, Castration-Resistant
5
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
5
Lymphoma, B-Cell, Marginal Zone
5
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
4
Leukemia, Lymphocytic, Chronic, B-Cell
4
Leukemia, Biphenotypic, Acute
4
Leukemia
4
Ovarian Neoplasms
3
Lymphoproliferative Disorders
3
Lymphoma, T-Cell
3
Hodgkin Disease
3
Prostate Cancer Metastatic
2
Plasmablastic Lymphoma
2
Multiple Myeloma
2
Metastatic Castration-resistant Prostate Cancer
2
Melanoma
2
Lymphoma, T-Cell, Peripheral
2
Lymphoma, T-Cell, Cutaneous
2
Lymphoma, Mantle-Cell
2
Immunoblastic Lymphadenopathy
2
Interventions
peginterferon alfa-2b
1
liposomal doxorubicin
1
dolutegravir
1
belinostat
1
Zidovudine
1
Tenofovir
1
Taxes
1
Paclitaxel
1
Lomustine
1
Irinotecan
1
Introns
1
Gemcitabine
1
Doxorubicin
1
Cyclophosphamide
1
Carboplatin
1
Albumin-Bound Paclitaxel
1
3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia-Lymphoma, Adult T-Cell
×
Prednisone
×
90 days
×
Clear all
No trials found.